Benefits of the Magtrace®

Provides the best standard of cancer staging, regardless of your hospital setting and facilities.
Inject the tracer when it’s convenient for you and your patients – from 20 minutes up to 30 days ahead of surgery.
Eliminates issues with radioactive materials; reaches equivalent clinical outcomes [1–3].
Provides visual confirmation, as well as intuitive magnetic identification.
No reports of anaphylaxis in over 65,000 cases to date.
The Sentimag® and Magtrace® are FDA-cleared and CE-marked.

[1] Alvarado et al. (2019): Ann Surg Oncol. 26(11):3510–6. [2] Karakatsanis et al. (2016): Breast Cancer Res Treat. 157(2):281–94. [3] Teshome et al. (2016): Ann Surg Oncol. 23(5):1508–14.

Benefits of the Magseed®

Designed with the patient in mind – no radioactivity, reduced stress, less pain.
Placed in any soft tissue – breast lesion, lymph node, etc.
Can be implanted for as long as needed – always reliably detectable by Sentimag®
Smallest non-radioactive seed – ideal for lymph node placement
Decoupling of OR and radiology scheduling
Stays securely in place without migration from soft tissue.
Very low re-excision rate for lesions (11% averaged over multiple studies)
Sentimag® and Magseed® are CE-marked and FDA-cleared for soft tissue.

About the training

Includes

Training type

Schedule